Abionyx Pharma (XPAR:ABNX) Price-to-Operating-Cash-Flow : (As of May. 17, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma Price-to-Operating-Cash-Flow?

As of today (2024-05-17), Abionyx Pharma's share price is €1.09. Abionyx Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12. Hence, Abionyx Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Abionyx Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:ABNX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.395
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Abionyx Pharma's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €-0.04. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -67.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 21.00% per year.

During the past 11 years, Abionyx Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 62.10% per year. The lowest was -67.00% per year. And the median was 10.60% per year.

Abionyx Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Abionyx Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abionyx Pharma Price-to-Operating-Cash-Flow Chart

Abionyx Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Abionyx Pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Abionyx Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Abionyx Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abionyx Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abionyx Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Abionyx Pharma's Price-to-Operating-Cash-Flow falls into.

Abionyx Pharma Price-to-Operating-Cash-Flow Calculation

Abionyx Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.09	/	-0.122
	=

Abionyx Pharma's Share Price of today is €1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abionyx Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Abionyx Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Abionyx Pharma (XPAR:ABNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

609:Germany

Address

33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130

Website

https://www.abionyx.com

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines